The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase IIA clinical trial to evaluate a reversible Bruton’s tyrosine kinase inhibitor (BTKi) HBW-3220 capsules in patients with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL).
 
Ning Lee
Employment - Hyperway Pharmaceuticals
Leadership - Hyperway Pharmaceuticals
Stock and Other Ownership Interests - Hyperway Pharmaceuticals
 
Yingfu Li
Employment - Hyperway Pharmaceuticals
Leadership - Hyperway Pharmaceuticals
Stock and Other Ownership Interests - Hyperway Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Chengdu Hyperway Pharmaceutical
 
Yong Mao
Employment - Hyperway Pharmaceuticals
Leadership - Hyperway Pharmaceuticals
Stock and Other Ownership Interests - Hyperway Pharmaceuticals
 
Guanfeng Liu
Employment - Hyperway Pharmaceuticals
Leadership - Hyperway Pharmaceuticals
Stock and Other Ownership Interests - Hyperway Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Chengdu Hyperway Pharmaceutical
 
Jiang Li
Employment - Hyperway Pharmaceuticals
Leadership - Hyperway Pharmaceuticals
Stock and Other Ownership Interests - Hyperway Pharmaceuticals
 
Qingchun Liu
Employment - Hyperway Pharmaceuticals